nPOD donors
| nPOD case ID . | Donor type . | Age . | Diabetes duration (yr) . | HLA II . | % insulin-binding BND2 (pLN) . | % insulin-binding DN2 (pLN) . |
|---|---|---|---|---|---|---|
| 6523 | T1D | 12 | 3 | DR3-DQ2 | 57.10 | 90.9 |
| 6533 | T1D | 3 | 0 | DR4-DQ8 | 60.3 | 76.9 |
| 6536 | T1D | 20 | 4 | DR4-DQ8 | 13.3 | 30.4 |
| 6537 | ND | 33 | - | DR4-DQ8 | 0 | 0 |
| 6548 | ND | 20 | - | DR4-DQ8 | 0 | 0 |
| 6550 | T1D | 25 | 0 | Other | 45 | 48.1 |
| 6552 | ND | 33 | - | DR4-DQ8 | 0 | 0 |
| 6563 | T1D | 14 | 0 | Other | 23 | 42.9 |
| 6566 | T1D | 15 | 2 | DR4-DQ8 | 12.2 | 28.7 |
| nPOD case ID . | Donor type . | Age . | Diabetes duration (yr) . | HLA II . | % insulin-binding BND2 (pLN) . | % insulin-binding DN2 (pLN) . |
|---|---|---|---|---|---|---|
| 6523 | T1D | 12 | 3 | DR3-DQ2 | 57.10 | 90.9 |
| 6533 | T1D | 3 | 0 | DR4-DQ8 | 60.3 | 76.9 |
| 6536 | T1D | 20 | 4 | DR4-DQ8 | 13.3 | 30.4 |
| 6537 | ND | 33 | - | DR4-DQ8 | 0 | 0 |
| 6548 | ND | 20 | - | DR4-DQ8 | 0 | 0 |
| 6550 | T1D | 25 | 0 | Other | 45 | 48.1 |
| 6552 | ND | 33 | - | DR4-DQ8 | 0 | 0 |
| 6563 | T1D | 14 | 0 | Other | 23 | 42.9 |
| 6566 | T1D | 15 | 2 | DR4-DQ8 | 12.2 | 28.7 |